Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:2766:9-15.
doi: 10.1007/978-1-0716-3682-4_2.

Human Xenograft Model

Affiliations

Human Xenograft Model

Shuang Liu. Methods Mol Biol. 2024.

Abstract

Human-SCID grafting is a commonly used technique for the long-term investigation of rheumatoid arthritis (RA) explants. To establish a chimeric immunological system in NOD/SCID mice, RA patient-derived pannus tissue from the synovial membrane, articular cartilage, and bone can be transplanted subcutaneously. Same patient-derived peripheral mononuclear cell chimerism can be successfully achieved by intraperitoneal engraftment. This xenograft model is able to be used for the initial screening of human target-specified biologics.

Keywords: Articular tissue; NOD/SCID mouse; Peripheral mononuclear cell; Synovial invasion; Xenograft rheumatoid arthritis model.

PubMed Disclaimer

Similar articles

References

    1. Rendt KE, Barry TS, Jones DM, Richter CB, McCachren SS, Haynes BF (1993) Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. J Immunol 151:7324–7336 - DOI - PubMed
    1. Matsuno H, Yudoh K, Uzuki M, Kimura T (2001) The SCID-HuRAg mouse as a model for rheumatoid arthritis. Mod Rheumatol 11:6–9 - DOI - PubMed
    1. Sakuraba K, Fujimura K, Nakashima Y, Okazaki K, Fukushi J, Ohishi M et al (2015) Brief report: successful in vitro culture of rheumatoid arthritis synovial tissue explants at the air-liquid interface. Arthritis Rheum 67:887–892 - DOI
    1. Liu S, Hasegawa H, Takemasa E, Suzuki Y, Oka K, Kiyoi T et al (2017) Efficiency and safety of CRAC inhibitors in human rheumatoid arthritis xenograft models. J Immunol 199:1584–1595 - DOI - PubMed
    1. Maeshima K, Yamaoka K, Kubo S, Nakano K, Iwata S, Saito K et al (2012) The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-gamma and interleukin-17 production by human CD4+ T cells. Arthritis Rheum 64:1790–1798 - DOI - PubMed

Substances

LinkOut - more resources